196 related articles for article (PubMed ID: 24407106)
1. Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases.
Ananthakrishnan AN; Cheng SC; Cai T; Cagan A; Gainer VS; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1342-8.e1. PubMed ID: 24407106
[TBL] [Abstract][Full Text] [Related]
2. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
[TBL] [Abstract][Full Text] [Related]
3. Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases.
Ananthakrishnan AN; Cagan A; Cai T; Gainer VS; Shaw SY; Churchill S; Karlson EW; Murphy SN; Liao KP; Kohane I
Clin Gastroenterol Hepatol; 2016 Jul; 14(7):973-9. PubMed ID: 26905907
[TBL] [Abstract][Full Text] [Related]
4. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease.
Lutgens M; Vermeire S; Van Oijen M; Vleggaar F; Siersema P; van Assche G; Rutgeerts P; Oldenburg B;
Clin Gastroenterol Hepatol; 2015 Jan; 13(1):148-54.e1. PubMed ID: 25041864
[TBL] [Abstract][Full Text] [Related]
5. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
6. Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine.
Barnes BH; Borowitz SM; Saulsbury FT; Hellems M; Sutphen JL
J Pediatr Gastroenterol Nutr; 2004 May; 38(5):509-12. PubMed ID: 15097439
[TBL] [Abstract][Full Text] [Related]
7. Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease.
Miranda-García P; Chaparro M; Gisbert JP
Gastroenterol Hepatol; 2016 Oct; 39(8):508-15. PubMed ID: 27020243
[TBL] [Abstract][Full Text] [Related]
8. Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer.
Sun YH; Li J; Shu HJ; Li ZL; Qian JM
Clin Transl Oncol; 2019 Dec; 21(12):1680-1686. PubMed ID: 30955196
[TBL] [Abstract][Full Text] [Related]
9. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
[TBL] [Abstract][Full Text] [Related]
10. Colorectal Cancer Risk in Patients With Lynch Syndrome and Inflammatory Bowel Disease.
Derikx LA; Smits LJ; van Vliet S; Dekker E; Aalfs CM; van Kouwen MC; Nagengast FM; Nagtegaal ID; Hoogerbrugge N; Hoentjen F
Clin Gastroenterol Hepatol; 2017 Mar; 15(3):454-458.e1. PubMed ID: 27521512
[TBL] [Abstract][Full Text] [Related]
11. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease.
Beaugerie L; Svrcek M; Seksik P; Bouvier AM; Simon T; Allez M; Brixi H; Gornet JM; Altwegg R; Beau P; Duclos B; Bourreille A; Faivre J; Peyrin-Biroulet L; Fléjou JF; Carrat F;
Gastroenterology; 2013 Jul; 145(1):166-175.e8. PubMed ID: 23541909
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).
Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM
Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511
[TBL] [Abstract][Full Text] [Related]
13. Persistent or Recurrent Anemia Is Associated With Severe and Disabling Inflammatory Bowel Disease.
Koutroubakis IE; Ramos-Rivers C; Regueiro M; Koutroumpakis E; Click B; Schoen RE; Hashash JG; Schwartz M; Swoger J; Baidoo L; Barrie A; Dunn MA; Binion DG
Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1760-6. PubMed ID: 25862987
[TBL] [Abstract][Full Text] [Related]
14. Association of inflammatory bowel disease in first-degree relatives with risk of colorectal cancer: A nationwide case-control study in Sweden.
Wang K; Olén O; Emilsson L; Khalili H; Halfvarson J; Song M; Ludvigsson JF
Int J Cancer; 2023 Jun; 152(11):2303-2313. PubMed ID: 36760205
[TBL] [Abstract][Full Text] [Related]
15. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease.
Solem CA; Loftus EV; Tremaine WJ; Harmsen WS; Zinsmeister AR; Sandborn WJ
Inflamm Bowel Dis; 2005 Aug; 11(8):707-12. PubMed ID: 16043984
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer in elderly-onset inflammatory bowel disease: a 1969-2017 Scandinavian register-based cohort study.
Everhov ÅH; Erichsen R; Järås J; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sørensen HT; Olén O
Aliment Pharmacol Ther; 2022 Oct; 56(7):1168-1182. PubMed ID: 35916190
[TBL] [Abstract][Full Text] [Related]
17. Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases.
Ananthakrishnan AN; Cagan A; Cai T; Gainer VS; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
Clin Gastroenterol Hepatol; 2015 Feb; 13(2):322-329.e1. PubMed ID: 25041865
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory Bowel Disease-Associated Colorectal Cancer Epidemiology and Outcomes: An English Population-Based Study.
Birch RJ; Burr N; Subramanian V; Tiernan JP; Hull MA; Finan P; Rose A; Rutter M; Valori R; Downing A; Morris EJA
Am J Gastroenterol; 2022 Nov; 117(11):1858-1870. PubMed ID: 36327438
[TBL] [Abstract][Full Text] [Related]
20. Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study.
Bogach J; Pond G; Eskicioglu C; Seow H
Inflamm Bowel Dis; 2019 Nov; 25(12):1957-1965. PubMed ID: 31066449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
